Sentinel Modular Program for Propensity-Score Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia

    Basic Details
    Date
    Tuesday, July 4, 2017
    Type
    Publication
    Medical Product
    glipizide
    glyburide
    Health Outcome(s)
    hypoglycemia
    Description

    This project conducted a cohort assessment to evaluate the ability of the Sentinel Propensity Score Matching Tool to reproduce in an expedited fashion the known association between glyburide (versus glipizide) and serious hypoglycemia.

    Author(s)

    Meijia Zhou MHS; Shirley V. Wang PhD, ScM; Charles E. Leonard PharmD, MSCE; Joshua J. Gagne PharmD, ScD; Candace Fuller PhD; Christian Hampp PhD; Patrick Archdeacon MD; Sengwee Toh ScD; Aarthi Iyer MPH; Tiffany S. Woodworth MPH; Elizabeth Cavagnaro MPH; Catherine A. Panozzo PhD; Sophia Axtman; Ryan M. Carnahan PharmD, MS, BCPP; Elizabeth Chrischilles PhD, MS, Sean Hennessy PharmD, PhD

    Corresponding Author

    S. Hennessy, Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, 423 Guardian Drive/803 Blockley Hall, Philadelphia, PA 19104. Email: hennessy@upenn.edu.